Eliem Therapeutics Free Cash Flow (Quarterly) Trends

Eliem Therapeutics Inc (ELYM)

8.34 +0.69 (+9.02%) USD | NASDAQ | May 02, 16:00

8.34 0.00 (0.00%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-0.947M
September 30, 2023	3.49M
June 30, 2023	-7.965M
March 31, 2023	-15.18M
December 31, 2022	-8.449M
September 30, 2022	-4.175M
June 30, 2022	-13.97M
March 31, 2022	-10.78M

Date	Value
December 31, 2021	-7.884M
September 30, 2021	-12.97M
June 30, 2021	-8.481M
March 31, 2021	-6.74M
December 31, 2020	-5.624M
September 30, 2020	-2.381M
June 30, 2020	-3.768M
March 31, 2020	-2.325M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-15.18M

Minimum

Mar 2023

3.49M

Maximum

Sep 2023

-6.759M

Average

-7.312M

Median

Free Cash Flow (Quarterly) Benchmarks